Dr. Riad Salem, MD

NPI: 1164447645
Total Payments
$2.4M
2024 Payments
$365,923
Companies
34
Transactions
909
Medicare Patients
948
Medicare Billing
$68,184

Payment Breakdown by Category

Consulting$1.3M (55.9%)
Other$654,638 (27.6%)
Travel$326,043 (13.7%)
Research$44,548 (1.9%)
Food & Beverage$19,815 (0.8%)
Education$460.22 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $1.3M 258 55.9%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $392,085 68 16.5%
Travel and Lodging $326,043 325 13.7%
Acquisitions $123,728 2 5.2%
Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $95,770 5 4.0%
Unspecified $44,548 6 1.9%
Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program $28,667 3 1.2%
Food and Beverage $19,815 233 0.8%
Honoraria $10,888 6 0.5%
Grant $3,500 1 0.1%
Education $460.22 2 0.0%

Payments by Type

General
$2.3M
903 transactions
Research
$44,548
6 transactions

Top Paying Companies

Company Total Records Latest Year
Boston Scientific Corporation $753,558 285 $0 (2024)
Bard Peripheral Vascular, Inc. $422,946 146 $0 (2024)
Biocompatibles, Inc. $340,741 44 $0 (2019)
BTG International Canada Inc. $231,741 14 $0 (2018)
Eisai Inc. $147,152 102 $0 (2024)
Siemens Medical Solutions USA, Inc. $81,767 101 $0 (2024)
Cook Incorporated $70,584 16 $0 (2024)
BTG International, Inc. $49,172 8 $0 (2018)
AstraZeneca Pharmaceuticals LP $38,443 25 $0 (2024)
Sirtex Medical Inc $34,750 22 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $365,923 200 Boston Scientific Corporation ($196,758)
2023 $389,938 182 Boston Scientific Corporation ($146,509)
2022 $344,188 129 BOSTON SCIENTIFIC CORPORATION ($230,172)
2021 $217,346 76 Bard Peripheral Vascular, Inc. ($96,937)
2020 $208,951 83 Boston Scientific Corporation ($76,668)
2019 $232,957 73 Biocompatibles, Inc. ($151,474)
2018 $389,942 110 Biocompatibles, Inc. ($168,513)
2017 $223,466 56 BTG International Canada Inc. ($152,457)

All Payment Transactions

909 individual payment records from CMS Open Payments — Page 1 of 37

Date Company Product Nature Form Amount Type
12/26/2024 Bard Peripheral Vascular, Inc. Consulting Fee Cash or cash equivalent $650.00 General
12/17/2024 Bard Peripheral Vascular, Inc. Consulting Fee Cash or cash equivalent $910.00 General
12/14/2024 Boston Scientific Corporation TheraSphere Administration Set (Device) Food and Beverage In-kind items and services $23.76 General
Category: TheraSphere Administration Set_PI
12/11/2024 Eisai Inc. Lenvima (Drug) Consulting Fee Cash or cash equivalent $4,400.00 General
Category: Oncology
12/03/2024 TriSalus Life Sciences, Inc. TRINAV INFUSION SYSTEM (Device) Consulting Fee Cash or cash equivalent $20,000.00 General
Category: ONCOLOGY
11/24/2024 AstraZeneca Pharmaceuticals LP Consulting Fee Cash or cash equivalent $755.00 General
11/24/2024 AstraZeneca Pharmaceuticals LP Consulting Fee Cash or cash equivalent $755.00 General
11/21/2024 Boston Scientific Corporation TheraSphere Y90 Glass Microspheres 10 GBq (Device) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $9,800.00 General
Category: TheraSphere_PI
11/21/2024 Boston Scientific Corporation Grant In-kind items and services $3,500.00 General
Category: General - Therapies_PI
11/21/2024 Boston Scientific Corporation TheraSphere Y90 Glass Microspheres 10 GBq (Device) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,200.00 General
Category: TheraSphere_PI
11/21/2024 Boston Scientific Corporation TheraSphere Y90 Glass Microspheres 10 GBq (Device) Travel and Lodging Cash or cash equivalent $398.29 General
Category: TheraSphere_PI
11/21/2024 Boston Scientific Corporation TheraSphere Y90 Glass Microspheres 10 GBq (Device) Travel and Lodging Cash or cash equivalent $163.57 General
Category: TheraSphere_PI
11/20/2024 AstraZeneca Pharmaceuticals LP Consulting Fee Cash or cash equivalent $3,020.00 General
11/15/2024 TriSalus Life Sciences, Inc. TRINAV INFUSION SYSTEM (Device) Consulting Fee Cash or cash equivalent $4,225.00 General
Category: ONCOLOGY
11/15/2024 Genentech, Inc. Consulting Fee Cash or cash equivalent $2,565.00 General
11/15/2024 Genentech, Inc. Travel and Lodging In-kind items and services $463.35 General
11/15/2024 Genentech, Inc. Travel and Lodging In-kind items and services $393.28 General
11/15/2024 Genentech, Inc. Travel and Lodging Cash or cash equivalent $352.79 General
11/15/2024 Genentech, Inc. Food and Beverage In-kind items and services $218.85 General
11/15/2024 Boston Scientific Corporation EMBOLD Fibered (Device) Food and Beverage In-kind items and services $14.83 General
Category: Embold_PI
11/14/2024 Sirtex Medical Inc SIR-Spheres Microspheres (Device) Consulting Fee Cash or cash equivalent $650.00 General
Category: Interventional Oncology
11/12/2024 Bard Peripheral Vascular, Inc. Consulting Fee Cash or cash equivalent $812.50 General
11/09/2024 Boston Scientific Corporation TheraSphere Y90 Glass Microspheres 10 GBq (Device) Food and Beverage In-kind items and services $396.86 General
Category: TheraSphere_PI
11/08/2024 Boston Scientific Corporation TheraSphere Y90 Glass Microspheres 10 GBq (Device) Food and Beverage In-kind items and services $601.80 General
Category: TheraSphere_PI
11/07/2024 Boston Scientific Corporation TheraSphere Y90 Glass Microspheres 10 GBq (Device) Food and Beverage In-kind items and services $191.95 General
Category: TheraSphere_PI

Research Studies & Clinical Trials

Study Name Company Amount Records
PROTEUS BARD PERIPHERAL VASCULAR, INC. $10,528 1
PROTEUS Bard Peripheral Vascular, Inc. $9,860 1
PROTEUS PROJECT Bard Peripheral Vascular, Inc. $2,500 1
A PHASE III, OPEN-LABEL, RANDOMIZED STUDY EVALUATING THE EFFICACY AND SAFETY OF ATEZOLIZUMAB IN COMBINATION WITH BEVACIZUMAB VERSUS SORAFENIB IN PATIENTS WITH UNTREATED ADVANCED HEPATOCELLULAR CARCINOMA HCC F. Hoffmann-La Roche AG $2,110 2

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 9 272 292 $140,254 $16,975
2022 6 228 234 $136,328 $16,450
2021 7 342 344 $216,224 $26,445
2020 4 106 111 $62,948 $8,314
Total Patients
948
Total Services
981
Medicare Billing
$68,184
Procedure Codes
26

All Medicare Procedures & Services

26 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
36561 Insertion of central venous tube with port (5 years or older) Facility 2023 21 21 $52,542 $5,871 11.2%
36558 Insertion of tunneled central venous tube for infusion (5 years or older) Facility 2023 15 16 $29,328 $3,342 11.4%
49440 Insertion of stomach tube using fluoroscopic guidance with contrast Facility 2023 11 11 $14,168 $1,806 12.7%
36556 Insertion of non-tunneled central venous tube for infusion (5 years or older) Facility 2023 22 23 $14,973 $1,699 11.3%
50435 Replacement of kidney drainage tube using imaging guidance with review by radiologist Facility 2023 11 15 $10,355 $1,411 13.6%
77001 Fluoroscopic guidance for insertion or removal of central vein access device Facility 2023 57 61 $5,917 $944.71 16.0%
76937 Ultrasonic guidance for blood vessel access Facility 2023 68 73 $6,132 $911.78 14.9%
99152 Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes Facility 2023 54 59 $3,953 $660.19 16.7%
76942 Ultrasonic guidance for needle placement Facility 2023 13 13 $2,886 $330.32 11.4%
36561 Insertion of central venous tube with port (5 years or older) Facility 2022 22 23 $57,546 $6,925 12.0%
36558 Insertion of tunneled central venous tube for infusion (5 years or older) Facility 2022 21 21 $38,493 $4,712 12.2%
36556 Insertion of non-tunneled central venous tube for infusion (5 years or older) Facility 2022 25 25 $16,275 $1,648 10.1%
77001 Fluoroscopic guidance for insertion or removal of central vein access device Facility 2022 74 75 $7,275 $1,176 16.2%
50435 Replacement of kidney drainage tube using imaging guidance with review by radiologist Facility 2022 12 14 $10,355 $1,124 10.9%
76937 Ultrasonic guidance for blood vessel access Facility 2022 74 76 $6,384 $864.97 13.5%
36561 Insertion of central venous catheter and implanted device for infusion beneath the skin, patient 5 years or older Facility 2021 43 43 $107,586 $12,973 12.1%
36558 Insertion of central venous catheter for infusion, patient 5 years or older, tunneled Facility 2021 28 28 $51,324 $6,365 12.4%
36556 Insertion of central venous catheter for infusion, patient 5 years or older, not tunneled Facility 2021 27 27 $17,577 $2,023 11.5%
36581 Replacement of central venous catheter, tunneled without port or pump Facility 2021 12 12 $19,140 $1,844 9.6%
77001 Fluoroscopic guidance for insertion, replacement or removal of central venous access device Facility 2021 107 109 $10,573 $1,785 16.9%
76937 Ultrasound guidance for accessing into blood vessel Facility 2021 97 97 $8,148 $1,153 14.1%
99152 Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 15 minutes Facility 2021 28 28 $1,876 $302.96 16.1%
36561 Insertion of central venous catheter and implanted device for infusion beneath the skin, patient 5 years or older Facility 2020 14 14 $35,028 $4,410 12.6%
36558 Insertion of central venous catheter for infusion, patient 5 years or older Facility 2020 11 11 $20,163 $2,655 13.2%
77001 Fluoroscopic guidance for insertion, replacement or removal of central venous access device Facility 2020 39 41 $3,977 $678.13 17.1%

About Dr. Riad Salem, MD

Dr. Riad Salem, MD is a Vascular & Interventional Radiology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164447645.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Riad Salem, MD has received a total of $2.4M in payments from pharmaceutical and medical device companies, with $365,923 received in 2024. These payments were reported across 909 transactions from 34 companies. The most common payment nature is "Consulting Fee" ($1.3M).

As a Medicare-enrolled provider, Salem has provided services to 948 Medicare beneficiaries, totaling 981 services with total Medicare billing of $68,184. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.

Practice Information

  • Specialty Vascular & Interventional Radiology
  • Location Chicago, IL
  • Active Since 07/13/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 2085R0204X
  • Entity Type Individual
  • NPI Number 1164447645

Products in Payments

  • THERASPHERE - BIO (Device) $616,962
  • TheraSphere Y90 Glass Microspheres 10 GBq (Device) $370,689
  • Lenvima (Drug) $147,118
  • General - Therapies (Device) $111,422
  • GENERAL - THERAPIES (Device) $67,781
  • TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) (Device) $46,354
  • SIR-Spheres Microspheres (Device) $34,750
  • GENERAL PAIN MANAGEMENT (Device) $32,608
  • TRINAV INFUSION SYSTEM (Device) $25,484
  • GENERAL THERAPIES (Device) $24,800
  • IMFINZI (Biological) $18,679
  • TECENTRIQ (Biological) $18,564
  • THERASPHERE (Device) $17,525
  • SMART PORT CT (Device) $15,600
  • TheraSphere (Device) $13,650
  • Tecentriq (Biological) $11,774
  • Clinical Trial Product (Device) $10,325
  • Cook Medical Embolization (Device) $9,169
  • Embosphere Microspheres (Device) $8,925
  • Wrapsody Stent Graft (Device) $8,497

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Vascular & Interventional Radiology Doctors in Chicago